{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:06Z","timestamp":1793382906949,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073810"],"award-info":[{"award-number":["82073810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3300904"],"award-info":[{"award-number":["2022YFC3300904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.taap.2024.116918","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T15:09:56Z","timestamp":1711984196000},"page":"116918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl"],"prefix":"10.1016","volume":"486","author":[{"given":"Xiao-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2024.116918_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108321","article-title":"Opioid-related overdose mortality in the era of fentanyl: monitoring a shifting epidemic by person, place, and time","volume":"216","author":"Althoff","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.taap.2024.116918_bb0010","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.taap.2024.116918_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.116918_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.120.000124","article-title":"Monoclonal antibodies counteract opioid-induced behavioral and toxic effects in mice and rats","volume":"375","author":"Baehr","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.116918_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.121.001048","article-title":"Pharmacological profiling of antifentanyl monoclonal antibodies in combination with naloxone in pre- and postexposure models of fentanyl toxicity","volume":"381","author":"Baehr","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.116918_bb0030","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1021\/acs.jafc.1c03657","article-title":"Hydrophobic moiety of capsaicinoids haptens enhancing antibody performance in immunoassay: evidence from computational chemistry and molecular recognition","volume":"69","author":"Bai","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2024.116918_bb0035","doi-asserted-by":"crossref","first-page":"1991552","DOI":"10.1080\/19420862.2021.1991552","article-title":"Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice","volume":"13","author":"Ban","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/j.taap.2024.116918_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11469-021-00621-z","article-title":"The M3-TT vaccine decreases the antinociceptive effects of morphine and heroin in mice","volume":"21","author":"Barbosa-M\u00e9ndez","year":"2021","journal-title":"Int. J. Ment. Heal. Addict."},{"key":"10.1016\/j.taap.2024.116918_bb0045","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/acs.molpharmaceut.0c00497","article-title":"Novel vaccine that blunts fentanyl effects and sequesters ultrapotent fentanyl analogues","volume":"17","author":"Barrientos","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.taap.2024.116918_bb0050","doi-asserted-by":"crossref","first-page":"13294","DOI":"10.1021\/jacs.0c05219","article-title":"Enhancement of a heroin vaccine through hapten deuteration","volume":"142","author":"Belz","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.taap.2024.116918_bb0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate vaccine immunotherapy for substance use disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2024.116918_bb0060","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.taap.2024.116918_bb0065","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.taap.2024.116918_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43126-0","article-title":"Investigation of monoclonal antibody CSX-1004 for fentanyl overdose","volume":"14","author":"Bremer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2024.116918_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/vim.2017.0049","article-title":"Adjuvants for animal vaccines","volume":"31","author":"Burakova","year":"2018","journal-title":"Viral Immunol."},{"key":"10.1016\/j.taap.2024.116918_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2012.10.069","article-title":"High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants","volume":"31","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.taap.2024.116918_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.110533","article-title":"Production of a specific monoclonal antibody for 1-naphthol based on novel hapten strategy and development of an easy-to-use ELISA in urine samples","volume":"196","author":"Chen","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.taap.2024.116918_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.136533","article-title":"Lateral flow immunoassay based on gold nanoparticles for rapid and sensitive detection of zoxamide in grape, tomato and cucumber samples","volume":"426","author":"Cheng","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.taap.2024.116918_bb0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/emj.2003.009613","article-title":"Naloxone in opioid poisoning: walking the tightrope","volume":"22","author":"Clarke","year":"2005","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.taap.2024.116918_bb0100","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/acs.jmedchem.6b00084","article-title":"Methamphetamine vaccines: improvement through hapten design","volume":"59","author":"Collins","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2024.116918_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.forsciint.2006.03.018","article-title":"LC-MS\/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple durogesic transdermal therapeutic systems","volume":"169","author":"Coopman","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.taap.2024.116918_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109740","article-title":"Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner","volume":"243","author":"Elder","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.taap.2024.116918_bb0115","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1016\/j.bmcl.2014.08.035","article-title":"A human recombinant monoclonal antibody to cocaine: preparation, characterization and behavioral studies","volume":"24","author":"Eubanks","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.taap.2024.116918_bb0120","doi-asserted-by":"crossref","DOI":"10.1021\/acschembio.1c00026","article-title":"A highly efficacious carfentanil vaccine that blunts opioid-induced antinociception and respiratory depression","author":"Eubanks","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.taap.2024.116918_bb0125","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acschemneuro.3c00455","article-title":"An engineered human-antibody fragment with fentanyl pan-specificity that reverses carfentanil-induced respiratory depression","volume":"14","author":"Eubanks","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2024.116918_bb0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(73)91879-5","article-title":"Treatment of drug overdosage with naloxone, a specific narcotic antagonists","volume":"301","author":"Evans","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2024.116918_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pbb.2016.09.008","article-title":"Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques","volume":"150-151","author":"Evans","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2024.116918_bb0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.taap.2024.116918_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0376-8716(97)00121-X","article-title":"Development of a therapeutic vaccine for the treatment of cocaine addiction","volume":"48","author":"Fox","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.taap.2024.116918_bb0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschemneuro.6b00389","article-title":"Influencing antibody-mediated attenuation of methamphetamine CNS distribution through vaccine linker design","volume":"8","author":"Gooyit","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2024.116918_bb0155","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1016\/j.vaccine.2022.03.053","article-title":"Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder","volume":"40","author":"Hamid","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.taap.2024.116918_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/s12264-022-00872-3","article-title":"Unique pharmacology, brain dysfunction, and therapeutic advancements for fentanyl misuse and abuse","author":"Han","year":"2022","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.taap.2024.116918_bb0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0968-4328(99)00036-0","article-title":"Keyhole limpet hemocyanin (KLH): a biomedical review","volume":"30","author":"Harris","year":"1999","journal-title":"Micron"},{"key":"10.1016\/j.taap.2024.116918_bb0170","doi-asserted-by":"crossref","first-page":"2122507","DOI":"10.1080\/21645515.2022.2122507","article-title":"Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development","volume":"18","author":"Hicks","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.taap.2024.116918_bb0175","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/acschemneuro.8b00079","article-title":"Efficacious vaccine against heroin contaminated with fentanyl","volume":"9","author":"Hwang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2024.116918_bb0180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsat.2016.07.005","article-title":"Awareness and attitudes toward intranasal naloxone rescue for opioid overdose prevention","volume":"69","author":"Kirane","year":"2016","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.taap.2024.116918_bb0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"Koehler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.taap.2024.116918_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2024.116918_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.taap.2024.116918_bb0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","article-title":"Abuse of fentanyl: an emerging problem to face","volume":"289","author":"Kuczynska","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.taap.2024.116918_bb0205","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.tvjl.2011.02.008","article-title":"Pharmacokinetics of subcutaneous fentanyl in greyhounds","volume":"190","author":"KuKanich","year":"2011","journal-title":"Vet. J."},{"key":"10.1016\/j.taap.2024.116918_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugpo.2016.08.004","article-title":"Risk of fentanyl overdose among clients of the Sydney medically supervised injecting Centre","volume":"37","author":"Latimer","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.taap.2024.116918_bb0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/jacsau.0c00057","article-title":"Broadly neutralizing synthetic cannabinoid vaccines","volume":"1","author":"Lin","year":"2021","journal-title":"JACS Au"},{"key":"10.1016\/j.taap.2024.116918_bb0220","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1073\/pnas.86.11.4220","article-title":"Mouse\/human chimeric monoclonal antibody in man: kinetics and immune response","volume":"86","author":"Lobuglio","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2024.116918_bb0225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1124\/dmd.118.083857","article-title":"A recombinant humanized anticocaine monoclonal antibody alters the urinary clearance of cocaine and its metabolites in rats","volume":"47","author":"Marckel","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2024.116918_bb0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13543784.2023.2187286","article-title":"The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis","volume":"32","author":"Martinez","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.taap.2024.116918_bb0235","article-title":"The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City","volume":"4","author":"Morgan","year":"2022","journal-title":"Drug Alcohol Depend. Rep."},{"key":"10.1016\/j.taap.2024.116918_bb0240","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0264-410X(84)90073-2","article-title":"Preparation of a vector containing a chimeric gene - for use in expression of foreign genes","volume":"2","author":"Moss","year":"1984","journal-title":"Vaccine"},{"key":"10.1016\/j.taap.2024.116918_bb0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2018.06.026","article-title":"Prophylactic vaccination protects against the development of oxycodone self-administration","volume":"138","author":"Nguyen","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.116918_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.007","article-title":"Immunomodulatory properties of the vaccine adjuvant alum","volume":"28","author":"Oleszycka","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.taap.2024.116918_bb0255","doi-asserted-by":"crossref","first-page":"14089","DOI":"10.1021\/jacs.9b07294","article-title":"Consequence of hapten stereochemistry: an efficacious methamphetamine vaccine","volume":"141","author":"Olson","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.taap.2024.116918_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109398","article-title":"Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021","volume":"234","author":"Palamar","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.taap.2024.116918_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.116918_bb0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.116918_bb0275","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2006.01.026","article-title":"Engineering of therapeutic antibodies to minimize immunogenicity and optimize function","volume":"58","author":"Presta","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.taap.2024.116918_bb0280","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.117.247049","article-title":"Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats","volume":"365","author":"Raleigh","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.116918_bb0285","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.116918_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108653","article-title":"Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder","volume":"195","author":"Raleigh","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.116918_bb0295","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1021\/acs.jmedchem.0c01042","article-title":"Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity","volume":"63","author":"Robinson","year":"2020","journal-title":"J. Med. Chem."},{"issue":"20\u201332","key":"10.1016\/j.taap.2024.116918_bb0300","article-title":"Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding","volume":"31","author":"Rodarte","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.taap.2024.116918_bb0305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2009.04.011","article-title":"Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats","volume":"93","author":"Roiko","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2024.116918_bb0310","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2017","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.taap.2024.116918_bb0315","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1021\/jacs.9b04872","article-title":"Monoclonal antibodies for combating synthetic opioid intoxication","volume":"141","author":"Smith","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.taap.2024.116918_bb0320","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpain.2014.08.010","article-title":"The fentanyl story","volume":"15","author":"Stanley","year":"2014","journal-title":"J. Pain"},{"key":"10.1016\/j.taap.2024.116918_bb0325","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","article-title":"First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.taap.2024.116918_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051553","article-title":"Design, synthesis, and in vivo evaluation of C1-linked 4,5-epoxymorphinan haptens for heroin vaccines","volume":"27","author":"Sulima","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2024.116918_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112049","article-title":"A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl","volume":"42","author":"Triller","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.taap.2024.116918_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120098","article-title":"Current status of vaccines for substance use disorders: a brief review of human studies","volume":"434","author":"Truong","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.taap.2024.116918_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173242","article-title":"Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors","volume":"208","author":"Varshneya","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2024.116918_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114805","article-title":"Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated","volume":"195","author":"Varshneya","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2024.116918_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173572","article-title":"Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression","volume":"226","author":"Varshneya","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2024.116918_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175587","article-title":"Biopharmaceuticals against substance use disorders \u2013 present and future","volume":"944","author":"Vavilis","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2024.116918_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121326","article-title":"Modifying naloxone to reverse fentanyl-induced overdose","volume":"611","author":"Voronkov","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2024.116918_bb0370","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1039\/D0CC02107E","article-title":"A fentanyl vaccine constructed upon opsonizing antibodies specific for the Galalpha1-3Gal epitope","volume":"56","author":"Wang","year":"2020","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.taap.2024.116918_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10081253","article-title":"Development of cross-reactive antibodies for the identification and treatment of synthetic cannabinoid receptor agonist toxicity","volume":"10","author":"Worob","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.taap.2024.116918_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113879","article-title":"Optimization of bifunctional piperidinamide derivatives as sigma(1)R antagonists\/MOR agonists for treating neuropathic pain","volume":"226","author":"Xiong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2024.116918_bb0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14329","article-title":"Current status of immunotherapies for addiction","volume":"1489","author":"Xu","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.taap.2024.116918_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjac.2022.100134","article-title":"Effect of hapten structures on development of novel antibody against capsaicin and dihydrocapsaicin","volume":"50","author":"Zhang","year":"2022","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.taap.2024.116918_bb0395","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biomaterials.2017.11.021","article-title":"Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction","volume":"155","author":"Zhao","year":"2018","journal-title":"Biomaterials"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:43:14Z","timestamp":1715953394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":79,"alternative-id":["S0041008X24001169"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116918","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116918"}}